R I Shader - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R I Shader

Showing results (41-50 of 502) with videos related to

Pageof 51

Sort By:

Journal of Clinical Psychopharmacology|April 1, 1983

Propranolol's psychiatric side effectsR I Shader, D J Greenblatt

British Journal of Clinical Pharmacology|January 1, 1981

The use of benzodiazepines in clinical practiceR I Shader, D J Greenblatt

Rational Drug Therapy|April 1, 1984

Short half-life benzodiazepinesD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|June 1, 1984

Benzodiazepine overuse-misuseR I Shader, D J Greenblatt

Psychiatry in Medicine|January 1, 1971

Psychopharmacologic management of anxiety in the cardiac patientD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|October 1, 1993

MedWatch, the new FDA adverse effects reporting systemR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|December 1, 1994

Case 2: Dizzy Giuseppi or the vertiginous virtuosoR I Shader, J R Oesterheld

Journal of Clinical Pharmacology|February 1, 1987

Drug absorption rate: a critical component of bioequivalence assessment in psychopharmacologyD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|August 1, 1983

Shades of the patent medicine manR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|February 1, 1982

Lethality and behavioral side effects of chloroquineM I Good, R I Shader

Pageof 51

Search research articles

Showing results (41-50 of 502) with videos related to

Sort By:

Pageof 51

Journal of Clinical Psychopharmacology|April 1, 1983

Propranolol's psychiatric side effectsR I Shader, D J Greenblatt

British Journal of Clinical Pharmacology|January 1, 1981

The use of benzodiazepines in clinical practiceR I Shader, D J Greenblatt

Rational Drug Therapy|April 1, 1984

Short half-life benzodiazepinesD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|June 1, 1984

Benzodiazepine overuse-misuseR I Shader, D J Greenblatt

Psychiatry in Medicine|January 1, 1971

Psychopharmacologic management of anxiety in the cardiac patientD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|October 1, 1993

MedWatch, the new FDA adverse effects reporting systemR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|December 1, 1994

Case 2: Dizzy Giuseppi or the vertiginous virtuosoR I Shader, J R Oesterheld

Journal of Clinical Pharmacology|February 1, 1987

Drug absorption rate: a critical component of bioequivalence assessment in psychopharmacologyD J Greenblatt, R I Shader

Journal of Clinical Psychopharmacology|August 1, 1983

Shades of the patent medicine manR I Shader, D J Greenblatt

Journal of Clinical Psychopharmacology|February 1, 1982

Lethality and behavioral side effects of chloroquineM I Good, R I Shader

Pageof 51